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The pulmonary autograft or “Ross procedure” offers hopefor a durable, anticoagulant-free replacement option fora dysfunctional aortic valve. As a viable graft, it has thepotential for growth. The distinction between growth
and passive dilatation, however, may be problematic. We recently
encountered a case that graphically demonstrated dilatation of the
wall of the autograft both radiologically and grossly.
Clinical Summary 
A 19-year-old man with a history of aortic regurgitation caused by
a bicuspid aortic valve had undergone a Ross procedure at age 13
years. The inflow suture line of the pulmonary autograft had not
been reinforced with felt. A 24-mm pulmonary allograft valve had
been placed in the pulmonic position. At recent echocardiographic
follow-up, asymptomatic dilatation of the neo-aortic root without
valvular regurgitation or stenosis was identified. Magnetic reso-
nance imaging demonstrated dilatation of the neo-aortic root to 6.4
cm with a sharp transition to normal diameter (Figure 1). The pul-
monic allograft was functioning normally. 
At surgery, external inspection of the aorta suggested a
“neck” at the transition between autograft and native aorta
(Figure 2, A). This was confirmed at aortotomy (Figure 2, B and
C). The autograft leaflets and anulus appeared normal (Figure 2,
C). As suggested previously by T. E. David (personal communi-
cation, October 1999), the root was reconstructed with a scal-
loped graft preserving the autograft leaflets after the manner
described by Yacoub. Transesophageal echocardiography
demonstrated a competent valve at the end of the procedure. The
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excised autograft tissue demonstrated medial myxoid degenera-
tive changes and fibrosis by hematoxylin-eosin stain and severe
fragmentation of elastin fibers by Verhoeff–van Gieson stain. 
Discussion
Inclusive of the patient presented above, we have reoperated on 4
patients late after the Ross procedure for neo-aortic valve mal-
function (Table 1). In 1 patient, a 34-year-old woman with
Goldenhar syndrome and a history of ventricular septal defect and
aortic regurgitation, moderate aortic regurgitation developed as a
result of a torn leaflet 7 years after the Ross procedure. No dilata-
tion of the neo-aortic root was observed. The neo-aortic valve was
replaced with a mechanical valve within the pulmonary autograft.
Of the remaining 3 patients, all had aneurysmal dilatation of the
neo-aorta and all had bicuspid aortic valves with aortic regurgita-
tion as their original pathologic condition. One of these requested
a mechanical valve and underwent conventional composite root
replacement; a second received a pericardial xenograft valve con-
duit because of contraindications to anticoagulation; and the third
is the subject of the current clinical summary.
The potential for growth makes the pulmonary autograft uniquely
appealing for the pediatric population, and the promise of durability
without anticoagulation makes it attractive to the young adult.
Unfortunately, the most common indication for surgery among young
adults is bicuspid aortic valve disease, a condition thought to be asso-
ciated with intrinsic abnormality of the aortic wall. It has been rec-
ognized for a decade that the aortic root may be enlarged in patients
with a bicuspid aortic valve even without hemodynamically signifi-
cant functional abnormality. More recently, histochemical studies
have demonstrated an increased rate of smooth muscle cell apoptosis
in the aortic media of patients with bicuspid aortic valves, even in the
absence of gross dilatation.1 Biochemical analysis has also demon-
strated a decrease in collagen content strikingly similar to that
observed in Marfan syndrome.2 Elastin fragmentation, alterations in
smooth muscle cell orientation, and the changes characterized by the
term cystic medial necrosis have been observed in both the ascending
aorta and pulmonary artery of patients undergoing the Ross operation
for bicuspid aortic valve disease.3
The clinical correlate of these laboratory observations has been
reported previously. David and colleagues4 identified a statistically
significant increase over time in the diameter of the sinuses of
Valsalva, the aortic anulus, and the sinotubular junction among
patients with bicuspid aortic valves undergoing the Ross proce-
dure. Histologic analysis of the pulmonary autograft wall from
such patients showed degenerative changes of cystic medial necro-
sis.4,5 Our case graphically demonstrates the radiologic and gross
pathologic correlate of these histologic findings. 
Dilatation of the anulus after the Ross procedure has led to
the recommendation by some that the inflow suture line be rein-
forced with prosthetic material. We observed significant dilata-
Figure 1. Magnetic resonance images of the neo-aortic root demonstrating dilatation of the pulmonary autograft and
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Figure 2. Intraoperative photographs confirming the transition to normal diameter aorta at the distal suture line. A,
External appearance of the neo-aortic root with a perceptible narrowing at the distal anastomosis (arrows). B and
C, Internal appearance of the transition between autograft and aorta demonstrating a “neck.” D, The normal appear-
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tion of the wall of the autograft, however, a complication
unlikely to be affected by annular reinforcement. David and col-
leagues4 have suggested that the root inclusion technique be
considered in cases of bicuspid aortic valve. Our observations
support this suggestion. 
Photographs were provided by Cynthia J. Camillo, RN, MS,
CCSN.
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TABLE 1. Patients undergoing reoperation after failed Ross procedure
Interval after Diameter of Valve disease Procedure at
Age (y) Sex Original disease Ross procedure neo-aorta at reoperation reoperation
34 F VSD + VSD 7 y Normal Moderate AR and severe PS Mechanical AVR and pul-
monary allograft
39 M BAV with AR 9 y 6.0 cm Moderate AR and severe PS Composite root replace-
ment and pulmonary allo-
graft
30 M BAV with AR 6 y 5.0 cm Severe AR and severe PS Pericardial valve conduit 
and pulmonary allograft
19 M BAV with AR 7 y 6.4 cm No AR or PS Yacoub root reconstruction
AR, Aortic regurgitation; AVR, aortic valve replacement; BAV, bicuspid aortic valve; PS, pulmonic stenosis; VSD, ventricular septal defect.
